<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1260288</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2023.1260288</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Network pharmacology-based exploration identified the antiviral efficacy of Quercetin isolated from mulberry leaves against enterovirus 71 via the NF-&#x3ba;B signaling pathway</article-title>
<alt-title alt-title-type="left-running-head">Liu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1260288">10.3389/fphar.2023.1260288</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liu</surname>
<given-names>Tianrun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2392344/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Yingyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Lumeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiaomeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yuxuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gai</surname>
<given-names>Xuejie</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Lei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Limin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/752356/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Baixin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Medicine</institution>, <institution>Jiamusi University</institution>, <addr-line>Jiamusi</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>The Affiliated First Hospital</institution>, <institution>Jiamusi University</institution>, <addr-line>Jiamusi</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>School of Medicine</institution>, <institution>Dalian University</institution>, <addr-line>Dalian</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/217921/overview">Mythily Srinivasan</ext-link>, Indiana University, Purdue University Indianapolis, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/218632/overview">Sreekanth Gopinathan Pillai</ext-link>, Indian Institute of Chemical Technology (CSIR), India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1961056/overview">Yongai Xiong</ext-link>, Zunyi Medical University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/198064/overview">Madhu Khanna</ext-link>, University of Delhi, India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Lei Liu, <email>Liulei@jmsu.edu.cn</email>; Limin Yang, <email>yanglimin@dlu.edu.cn</email>; Baixin Wang, <email>wbaixin@163.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1260288</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Liu, Li, Wang, Zhang, Zhang, Gai, Chen, Liu, Yang and Wang.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Liu, Li, Wang, Zhang, Zhang, Gai, Chen, Liu, Yang and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Introduction:</bold> Mulberry leaf (ML) is known for its antibacterial and anti-inflammatory properties, historically documented in &#x201c;Shen Nong&#x2019;s Materia Medica&#x201d;. This study aimed to investigate the effects of ML on enterovirus 71 (EV71) using network pharmacology, molecular docking, and <italic>in vitro</italic> experiments.</p>
<p>
<bold>Methods:</bold> We successfully pinpointed shared targets between mulberry leaves (ML) and the EV71 virus by leveraging online databases. Our investigation delved into the interaction among these identified targets, leading to the identification of pivotal components within ML that possess potent anti-EV71 properties. The ability of these components to bind to the targets was verified by molecular docking. Moreover, bioinformatics predictions were used to identify the signaling pathways involved. Finally, the mechanism behind its anti-EV71 action was confirmed through <italic>in vitro</italic> experiments.</p>
<p>
<bold>Results:</bold> Our investigation uncovered 25 active components in ML that targeted 231 specific genes. Of these genes, 29 correlated with the targets of EV71. Quercetin, a major ingredient in ML, was associated with 25 of these genes. According to the molecular docking results, Quercetin has a high binding affinity to the targets of ML and EV71. According to the KEGG pathway analysis, the antiviral effect of Quercetin against EV71 was found to be closely related to the NF-&#x03BA;B signaling pathway. The results of immunofluorescence and Western blotting showed that Quercetin significantly reduced the expression levels of VP1, TNF-&#x3b1;, and IL-1&#x3b2; in EV71-infected human rhabdomyosarcoma cells. The phosphorylation level of NF-&#x3ba;B p65 was reduced, and the activation of NF-&#x3ba;B signaling pathway was suppressed by Quercetin. Furthermore, our results showed that Quercetin downregulated the expression of JNK, ERK, and p38 and their phosphorylation levels due to EV71 infection.</p>
<p>
<bold>Conclusion:</bold> With these findings in mind, we can conclude that inhibiting the NF-&#x3ba;B signaling pathway is a critical mechanism through which Quercetin exerts its anti-EV71 effectiveness.</p>
</abstract>
<kwd-group>
<kwd>mulberry leaves</kwd>
<kwd>Quercetin</kwd>
<kwd>network pharmacology</kwd>
<kwd>enterovirus type 71</kwd>
<kwd>NF-kB</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Experimental Pharmacology and Drug Discovery</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Hand, foot, and mouth disease (HFMD) stands as a prevalent childhood infectious ailment primarily attributed to more than 20 enteroviruses. The prognosis for HFMD is generally optimistic, characterized by self-limiting symptoms that typically abate within a week (<xref ref-type="bibr" rid="B102">Zhang et al., 2022</xref>). However, certain neurological complications such as encephalomyelitis, brainstem encephalitis, and aseptic meningitis (<xref ref-type="bibr" rid="B27">Gonzalez et al.,2019</xref>) can rapidly lead to neurogenic pulmonary edema (<xref ref-type="bibr" rid="B82">Wang et al.,2019</xref>) and, in severe cases, even death. Enterovirus type 71 (EV71)is the most common viral culprit behind these severe complications (<xref ref-type="bibr" rid="B90">Yang et al., 2022</xref>). Currently, no clinically effective drugs exist, and symptomatic treatment remains the primary approach (<xref ref-type="bibr" rid="B46">Liu et al., 2015</xref>). HFMD has experienced multiple outbreaks worldwide, posing significant public health concerns and imposing substantial life safety risks and economic burdens on many countries (<xref ref-type="bibr" rid="B38">Solomon et al., 2010</xref>).</p>
<p>Chinese medicine considers virus infections as the invasion of cold and malevolent energy into the body. When the body&#x2019;s defense is weak, this energy can easily invade. However, if the body&#x2019;s defense is strong, it can resist such invasion (<xref ref-type="bibr" rid="B39">Li et al., 2020</xref>). Traditional Chinese medicine, with a history spanning five thousand years, has been routinely used to treat pandemics and endemic diseases, forming a comprehensive theoretical system for the prevention and treatment of deadly epidemics, referred to as &#x201c;plagues&#x201d; in ancient China (<xref ref-type="bibr" rid="B60">Qi and Tang, 2021</xref>). Traditional Chinese medicine is widely employed for antiviral purposes (<xref ref-type="bibr" rid="B87">Wu t al. 2021</xref>) by restoring the body&#x2019;s overall balance to counteract the harmful effects of viral infections (<xref ref-type="bibr" rid="B10">Chen and Ye, 2022</xref>). Numerous traditional Chinese medicines have been proven to possess antiviral properties (<xref ref-type="bibr" rid="B28">Guan et al., 2020</xref>; <xref ref-type="bibr" rid="B31">Kang et al., 2021</xref>; <xref ref-type="bibr" rid="B37">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="B15">Cui et al., 2022</xref>) capable of directly acting on viruses and stimulating the immune system to induce interferon production, thereby indirectly inactivating viruses (<xref ref-type="bibr" rid="B30">Huang et al., 2022</xref>).</p>
<p>Mulberry leaves (ML), derived from the Moraceae plant, are known for their antibacterial and antiviral effects (<xref ref-type="bibr" rid="B9">Chen et al., 2021</xref>). However, their potential anti-EV71 virus effect remains unexplored. This study aimed to investigate the potential of mulberry leaves in EV71 virus infection by predicting key target genes and signaling pathways involved in ML-mediated antiviral mechanisms through network pharmacology, bioinformatics, <italic>in vitro</italic> experiments, and medical statistics.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Screening active components and target genes of ML</title>
<p>To screen the active components and target genes of ML, we employed the traditional Chinese medicine database TCMSP (<ext-link ext-link-type="uri" xlink:href="https://old.tcmsp-e.com/">https://old.tcmsp-e.com/</ext-link>). The screening criteria were defined as oral availability (OB) &#x2265; 30 and drug-likeness (DL) &#x2265; 0.18 (<xref ref-type="bibr" rid="B16">Cui et al., 2021</xref>). These criteria allowed us to identify the critical active ML ingredients and retrieve their target information. The target information was standardized using the Uniprot database to obtain the Gene name. Finally, we employed Cytoscape (V3.9.1) software to visualize the network diagram illustrating the connections between the &#x201c;Chinese medicine-active ingredient-target gene.&#x201d;</p>
</sec>
<sec id="s2-2">
<title>2.2 Construction of a protein interaction network diagram for target genes in ML</title>
<p>For the analysis of target genes in ML, we employed the STRING database (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>). The biological species &#x201c;<italic>Homo sapiens</italic>&#x201d; was specifically chosen, and the minimum interaction score was set at a medium confidence level (0.400). The resulting protein-protein interaction (PPI) network diagram was thoroughly examined, and the Cytoscape (V3.9.1) software was utilized to enhance the clarity of the PPI network by emphasizing the interaction scores.</p>
</sec>
<sec id="s2-3">
<title>2.3 Retrieval of EV71 virus genes and screening of Anti-EV71 related genes in ML</title>
<p>The GENECARDS database (<ext-link ext-link-type="uri" xlink:href="https://www.genecards.org">https://www.genecards.org</ext-link>) and NCBI database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov">https://www.ncbi.nlm.nih.gov</ext-link>) were queried using &#x201c;EV71&#x201d;to retrieve the relevant genes associated with the EV71 virus. With the help of the VENN graph, we compared target genes of ML and EV71 viruses to identify potential anti-EV71 genes for ML. (<ext-link ext-link-type="uri" xlink:href="http://jvenn.toulouse.inra.fr/app/example.html">http://jvenn.toulouse.inra.fr/app/example.html</ext-link>). Cytoscape (V3.9.1) was used to visualize potential target genes and their corresponding active components.</p>
</sec>
<sec id="s2-4">
<title>2.4 Molecular docking</title>
<p>Based on the research mentioned above, we identified the main components of ML and its target genes. The top ten target genes were retrieved from the PDB protein database (<ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/">https://www.rcsb.org/</ext-link>) in PDB format, using &#x201c;<italic>Homo sapiens</italic>&#x201d; and &#x201c;A&#x2264;2.5&#x201d;as the specified settings. These PDB files underwent preprocessing, including water and residue removal, using the MOE 2019.0102 software. The CID numbers corresponding to the top ten active ingredients with antiviral effects in ML were obtained from the TCMSP database. These CID numbers were then retrieved from the PubChem database to retrieve the SDF file containing their 3D molecular structures (<ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</ext-link>). Subsequently, utilizing the MOE 2019.0102 software, a small molecule library was constructed based on the obtained SDF files. Finally, molecular docking was performed between the processed macromolecule receptors and the ligands in the small molecule library.</p>
</sec>
<sec id="s2-5">
<title>2.5 GO functional enrichment and KEGG pathway analysis</title>
<p>An analysis was conducted using the DAVID database to explore the potential genes implicated in the anti-EV71 activity of Quercetin, the primary component of ML (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/home.jsp">https://david.ncifcrf.gov/home.jsp</ext-link>). Enrichment analysis of Gene Ontology (GO) functions and KEGG signaling pathways was performed, considering a significance threshold of <italic>p</italic> &#x3c; 0.05. The top 15 enriched GO functions and KEGG signaling pathways were selected based on the obtained <italic>p</italic> values. The resulting enriched information was visualized on the MICROBIOTIC website (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.com.cn/">http://www.bioinformatics.com.cn/</ext-link>).</p>
</sec>
<sec id="s2-6">
<title>2.6 <italic>In vitro</italic> experimental study of quercetin against EV71 virus</title>
<sec id="s2-6-1">
<title>2.6.1 Cytotoxicity assay of quercetin and virus TCID<sub>50</sub> assay</title>
<p>A stock solution of Quercetin (Sigma-Aldrich Cat. No.: CAS6151-25-3) was meticulously prepared at a concentration of 200&#xa0;mM in DMSO, subsequently undergoing filtration through an organic microporous membrane. Human rhabdomyosarcoma (RD) cells were uniformly seeded within 96-well plates, achieving a density of 2 &#xd7; 105&#xa0;cells/mL. Each well received 100&#xa0;&#x3bc;L of the cell suspension. To minimize the cytotoxicity of DMSO, it was diluted at a ratio of 1:1000. Quercetin stock solution was further diluted using 10% FBS in DMEM (Nissui Cat. No.: 05900) to a maximum concentration of 200&#xa0;&#x3bc;M, with subsequent equal-fold dilutions. A 200&#xa0;&#x3bc;L volume of the diluted solution was introduced into each well, where a monolayer of RD cells had been established. The cells were subsequently incubated at 37&#xb0;C with 5% CO<sub>2</sub> for 24, 48, and 72&#xa0;h. Cell viability assessment was performed using the CCK8 assay (Beyotime Cat. No.: C0039), aimed at identifying the non-toxic concentration (TC0) of Quercetin concerning RD cells. The EV71 virus was diluted with a 2% FBS maintenance solution (Beyotime Cat. No.: C0232) and used to infect RD cells at concentrations ranging from 10<sup>&#x2212;1</sup> to 10<sup>&#x2212;8</sup>. The TCID<sub>50</sub> of the EV71 virus was calculated using the Reed-Muench method.</p>
</sec>
<sec id="s2-6-2">
<title>2.6.2 Evaluation of Quercetin&#x2019;s inhibitory effect on EV71 virus-infected RD cells</title>
<p>To assess the impact of Quercetin on EV71 virus-infected RD cells, we determined the maximum non-toxic concentration of Quercetin and prepared dilutions in equal increments. RD cells were infected with 100 TCID50 of the virus as the infection concentration. Quercetin concentrations of 25, 12.5, 6.25, and 3.125&#xa0;&#x3bc;M were prepared using DMEM with 2% FBS as the solvent. Cells were treated with 100&#xa0;&#x3bc;L of the EV71 virus and Quercetin simultaneously for 2&#xa0;h. Subsequently, the Quercetin and virus were removed, the cells were washed once with PBS, and 200&#xa0;&#x3bc;L of DMEM containing 2% FBS was added. The inhibitory effect of Quercetin on the EV71 virus was assessed at 48&#xa0;h using the CCK-8 assay. In addition, varying concentrations of Quercetin were co-administered with EV71 to RD cells. After 48&#xa0;h, the viral supernatant was harvested and underwent three freeze-thaw cycles to release EV71 from the RD cells. Subsequently, the mixture was centrifuged at 3,500&#xa0;rpm for 15&#xa0;min, and the supernatant was collected. Finally, the TCID50 value of the EV71 virus was quantified in the presence of distinct concentrations of Quercetin.</p>
</sec>
<sec id="s2-6-3">
<title>2.6.3 Immunofluorescence analysis of Quercetin&#x2019;s effect on EV71 virus-infected RD cells</title>
<p>RD cells were seeded at 1 &#xd7; 105&#xa0;cells/mL concentration on 24-well plates and specialized cell slides. Upon reaching 80% confluency, a concentration of Quercetin, known for its significant anti-EV71 effect, was added to the cells, along with 100 TCID50 of EV71. After 48&#xa0;h, the cells were fixed with 4% paraformaldehyde for 15&#xa0;min and permeabilized with 0.2% TritonX-100 (diluted in PBS) for 10&#xa0;min at room temperature. A blocking solution containing 1% BSA, 3% donkey serum, and 0.1% TritonX-100 in PBS was applied at room temperature for 45&#xa0;min. The primary antibodies (VP-1, Invitrogen Cat. No.: WD3250882A, Abnova Cat. No.: MAB1255-M08, p-NF-&#x3ba;B p65, Santa Cruz Cat. No.: sc-135769, TNF-&#x3b1;, Cell Signaling Cat. No.: D2D4, IL-1&#x3b2;, Santa Cruz Cat. No.: sc-52012) diluted in blocking buffer were added and incubated overnight at 4&#xb0;C. The secondary antibodies (Alexa Fluor 488-labeled Goat Anti-Rabbit IgG and Alexa Fluor 488-labeled Goat Anti-Mouse IgG, Beyotime Cat. No.: A0423, A0428, (Alexa Fluor 594-labeled Goat Anti-Rabbit IgG and Alexa Fluor 594-labeled Goat Anti-Mouse IgG ZSGB-BIO Cat. No.: ZF-0516, ZF-0513) diluted in PBS were then incubated with the cells for 30&#x2013;40&#xa0;min at room temperature. DAPI staining was performed for 5&#xa0;min, followed by mounting with an anti-fluorescence quenching mounting solution. Confocal microscopy was used to capture images of the cells using wavelengths of 405&#xa0;nm, 561&#xa0;nm, and 488&#xa0;nm. The fluorescence intensity and expression of VP1, p-NF-&#x3ba;B p65, IL-1&#x3b2; and TNF-&#x3b1; were analyzed and quantified using the Image-Pro-Plus 6.0 image analysis system.</p>
</sec>
<sec id="s2-6-4">
<title>2.6.4 Western blot detection of NF-&#x3ba;B and MAPK signaling pathway-related proteins</title>
<p>RD cells were treated with Quercetin and EV71 for 48&#xa0;h, followed by harvesting and lysing in radioimmunoprecipitation assay (RIPA) lysis buffer (Beyotime Biotechnology, P0013C) containing a protease inhibitor cocktail. The lysates were centrifuged at 15,000&#xa0;rpm for 15&#xa0;min at 4&#xb0;C. The protein concentration was determined using the bicinchoninic acid reagent (Beyotime Biotechnology Co., Ltd.), and the proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The electrophoresis products were then transferred to polyvinylidene fluoride membranes (Merck, Darmstadt, Germany). Subsequently, the membranes were incubated with primary antibodies in 5% BSA in TBST (TBS with 0.05% Tween-20) overnight at 4&#xb0;C. Afterward, the membranes were washed three times with TBST for 10&#xa0;min each and then incubated with secondary antibodies at 37&#xb0;C for 1&#xa0;h. After this, the membranes were washed three times with TBST for 10&#xa0;min each time. Finally, chemiluminescent detection was performed using specific antibodies for the targeted proteins (ERK1/2, Santa Cruz Cat. No.: sc-514302; p-ERK, Santa Cruz Cat. No.: sc-7383; JNK, Santa Cruz Cat. No.: sc-7345; p-JNK, Santa Cruz Cat. No.: sc-6254; p38, Santa Cruz Cat. No.: sc-271120; p-p38, Santa Cruz Cat. No.: sc-7973; NF-&#x3ba;B p65, Santa Cruz Cat. No.: sc-515045, p-NF-&#x3ba;B p65, Santa Cruz Cat. No.: sc-135769). In the Western blotting analysis, it was observed that JNK exhibited strong signals at 54&#xa0;kDa, with only a faint signal detected at 46&#xa0;kDa. Similarly, ERK displayed strong signals at 42&#xa0;kDa, with a weak signal at 44&#xa0;kDa. This variance might be attributed to the antibodies&#x2019; specificity, prompting us to focus our analysis on the protein bands displaying strong signals.</p>
</sec>
</sec>
<sec id="s2-7">
<title>2.7 Statistical analysis</title>
<p>The data analysis and visualization were performed using GraphPad Prism version 8.0 software (GraphPad Software, San Diego, CA, United States). The data are presented as mean &#xb1; SD. The data from <italic>in vitro</italic> experiments were analyzed using a one-way ANOVA analysis of variance, followed by the Tukey test for multiple comparison tests. A <italic>p</italic>-value of &#x3c;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 The active ingredients and target genes of ML</title>
<p>Utilizing the TCMSP database, we retrieved the active ingredients of ML, resulting in 269 unique compounds. Through a screening process, we identified 29 key active ingredients, and their respective target information was extracted from the database. The target information was then mapped to gene names using the UniProt database, resulting in 498 related target genes (<xref ref-type="table" rid="T1">Table 1</xref>). After removing duplicate entries, we obtained 231 potential target genes associated with ML. Using Cytoscape software, we constructed a network diagram to visualize the association between ML active ingredients and target genes (v3.9.1) (<xref ref-type="fig" rid="F1">Figure 1A</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>ML&#x2019;s active ingredients with anti-EV71 effects.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">MOL ID</th>
<th align="left">Compound name</th>
<th align="left">OB</th>
<th align="left">DL</th>
<th align="left">Number of targets</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">MOL001771</td>
<td align="left">poriferast-5-en-3beta-ol</td>
<td align="left">36.91</td>
<td align="left">0.75</td>
<td align="left">2</td>
</tr>
<tr>
<td align="left">MOL002218</td>
<td align="left">scopolin</td>
<td align="left">56.45</td>
<td align="left">0.39</td>
<td align="left">2</td>
</tr>
<tr>
<td align="left">MOL002773</td>
<td align="left">beta-carotene</td>
<td align="left">37.18</td>
<td align="left">0.58</td>
<td align="left">22</td>
</tr>
<tr>
<td align="left">MOL003842</td>
<td align="left">Albanol</td>
<td align="left">83.16</td>
<td align="left">0.24</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">MOL003847</td>
<td align="left">Inophyllum E</td>
<td align="left">38.81</td>
<td align="left">0.85</td>
<td align="left">9</td>
</tr>
<tr>
<td align="left">MOL003850</td>
<td align="left">26-Hydroxy-dammara-20,24-dien-3-one</td>
<td align="left">44.41</td>
<td align="left">0.79</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">MOL003851</td>
<td align="left">Isoramanone</td>
<td align="left">39.97</td>
<td align="left">0.51</td>
<td align="left">3</td>
</tr>
<tr>
<td align="left">MOL003856</td>
<td align="left">Moracin B</td>
<td align="left">55.85</td>
<td align="left">0.23</td>
<td align="left">7</td>
</tr>
<tr>
<td align="left">MOL003857</td>
<td align="left">Moracin C</td>
<td align="left">82.13</td>
<td align="left">0.29</td>
<td align="left">6</td>
</tr>
<tr>
<td align="left">MOL003858</td>
<td align="left">Moracin D</td>
<td align="left">60.93</td>
<td align="left">0.38</td>
<td align="left">14</td>
</tr>
<tr>
<td align="left">MOL003859</td>
<td align="left">Moracin E</td>
<td align="left">56.08</td>
<td align="left">0.38</td>
<td align="left">11</td>
</tr>
<tr>
<td align="left">MOL003860</td>
<td align="left">Moracin F</td>
<td align="left">53.81</td>
<td align="left">0.23</td>
<td align="left">2</td>
</tr>
<tr>
<td align="left">MOL003861</td>
<td align="left">Moracin G</td>
<td align="left">75.78</td>
<td align="left">0.42</td>
<td align="left">4</td>
</tr>
<tr>
<td align="left">MOL003862</td>
<td align="left">Moracin H</td>
<td align="left">74.35</td>
<td align="left">0.51</td>
<td align="left">4</td>
</tr>
<tr>
<td align="left">MOL003879</td>
<td align="left">4-Prenylresveratrol</td>
<td align="left">40.54</td>
<td align="left">0.21</td>
<td align="left">17</td>
</tr>
<tr>
<td align="left">MOL000433</td>
<td align="left">FA</td>
<td align="left">68.96</td>
<td align="left">0.71</td>
<td align="left">3</td>
</tr>
<tr>
<td align="left">MOL000729</td>
<td align="left">Oxysanguinarine</td>
<td align="left">46.97</td>
<td align="left">0.87</td>
<td align="left">5</td>
</tr>
<tr>
<td align="left">MOL000098</td>
<td align="left">quercetin</td>
<td align="left">46.43</td>
<td align="left">0.28</td>
<td align="left">154</td>
</tr>
<tr>
<td align="left">MOL000358</td>
<td align="left">beta-sitosterol</td>
<td align="left">36.91</td>
<td align="left">0.75</td>
<td align="left">38</td>
</tr>
<tr>
<td align="left">MOL000422</td>
<td align="left">kaempferol</td>
<td align="left">41.88</td>
<td align="left">0.24</td>
<td align="left">63</td>
</tr>
<tr>
<td align="left">MOL000449</td>
<td align="left">Stigmasterol</td>
<td align="left">43.83</td>
<td align="left">0.76</td>
<td align="left">31</td>
</tr>
<tr>
<td align="left">MOL001439</td>
<td align="left">arachidonic acid</td>
<td align="left">45.57</td>
<td align="left">0.2</td>
<td align="left">38</td>
</tr>
<tr>
<td align="left">MOL001506</td>
<td align="left">Supraene</td>
<td align="left">33.55</td>
<td align="left">0.42</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">MOL003759</td>
<td align="left">Iristectorigenin A</td>
<td align="left">63.36</td>
<td align="left">0.34</td>
<td align="left">22</td>
</tr>
<tr>
<td align="left">MOL003975</td>
<td align="left">icosa-11,14,17-trienoic acid methyl ester</td>
<td align="left">44.81</td>
<td align="left">0.23</td>
<td align="left">0</td>
</tr>
<tr>
<td align="left">MOL006630</td>
<td align="left">Norartocarpetin</td>
<td align="left">54.93</td>
<td align="left">0.24</td>
<td align="left">5</td>
</tr>
<tr>
<td align="left">MOL007179</td>
<td align="left">Linolenic acid ethyl ester</td>
<td align="left">46.1</td>
<td align="left">0.2</td>
<td align="left">2</td>
</tr>
<tr>
<td align="left">MOL007879</td>
<td align="left">Tetramethoxyluteolin</td>
<td align="left">43.68</td>
<td align="left">0.37</td>
<td align="left">32</td>
</tr>
<tr>
<td align="left">MOL013083</td>
<td align="left">Skimmin (8CI)</td>
<td align="left">38.35</td>
<td align="left">0.32</td>
<td align="left">4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The presented table catalogs a series of active ingredients demonstrating anti-EV71 (Enterovirus 71) effects. Each row corresponds to a distinct compound. Compound name: This column contains the names of the active ingredients. OB (Oral Bioavailability): Oral bioavailability measures the extent to which an orally administered drug is absorbed into the systemic circulation. A higher numerical value indicates better absorption. DL (Drug-likeness): Drug-likeness shows a molecule&#x2019;s potential to possess drug-like properties. A value closer to 1 suggests that the molecule has favorable drug-like attributes. The number of targets denotes how many target molecules each compound interacts with. In drug discovery, drugs often interact with multiple molecules to achieve their therapeutic effects.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Target genes of ML. <bold>(A)</bold> &#x201c;ML-active ingredient-target&#x201d; network diagram. The orange oval in the outer circle of the figure is the target gene, the green diamond is the active ingredient of ML, and the purple &#x201c;V&#x201d; shape is the traditional Chinese medicine ML. <bold>(B)</bold> PPI network diagram of mulberry leaf-related genes. The larger the circle and the darker the color, the larger the node degree.</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 The PPI network of mulberry leaf target genes was constructed</title>
<p>The relevant target genes associated with ML were obtained from the STRING protein database, specifically focusing on <italic>Homo sapiens</italic> species. The resulting protein-protein interaction (PPI) network diagram comprised 221 nodes and 4001 edges, representing mulberry leaf-related target genes. The average node degree in the network was 36.2. To visualize the network diagram, Cytoscape software (V3.9.1) was utilized, and the CytoNCA program package within the software was employed to arrange the graph based on node degree, determining the size and color of the nodes. The top 10 genes with the highest node degrees were <italic>akt1, alb, il-6, tp53, tnf, ctnnb1, hsp90aa1, fos, egfr</italic>, and <italic>il-1b</italic> (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
</sec>
<sec id="s3-3">
<title>3.3 Potential target genes for anti-EV71 action of ML</title>
<p>Through the GENECARDS and NCBI databases, a search with &#x201c;EV71&#x201d;as the query resulted in the obtaining of 233 EV71-related genes. These genes were then compared with the mulberry leaf-related target genes using the Jvenn online tool, resulting in 29 common genes (<xref ref-type="fig" rid="F2">Figure 2A</xref>). We consider these 29 common genes as potential genes for ML in resisting the EV71 virus. The identified genes are: <italic>hspb1, chrm2, odc1, akt1, il10, egfr, ikbkb, map, casp3, mapk1, chuk, vcam1, ifng, il6, cxcl8, ccl2, bcl2, ccnd1, bax, cxcl10, ptgs2, icam1, il1b, nos3, hmox1, mapk14, tnf, il2, and g6pd.</italic>
</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Prediction of potential anti-EV71 target genes in ML. <bold>(A)</bold> Venn diagram of disease drug targets. The green part is the target gene related to the EV71 virus, and the blue part is the target gene associated with ML. <bold>(B)</bold> Network diagram of common genes and active components of ML. The orange ellipse in the outer circle is the potential target gene of mulberry leaf resistance to EV71, the green diamond in the inner circle is the active ingredient of traditional Chinese medicine corresponding to these potential target genes, and the &#x201c;V&#x201d; shape in the middle is the traditional Chinese medicine mulberry leaf.</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g002.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Quercetin is a key component of ML in the fight against EV71</title>
<p>The prediction of potential target genes of ML against EV71 yielded 29 genes. Further screening was conducted to identify the active ingredients of ML associated with these target genes. Utilizing Cytoscape software (V3.9.1), a network diagram illustrating the interplay between the potential target genes and active ingredients of ML was generated (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Significantly, 25 out of the 29 common targets were found to be closely associated with Quercetin, highlighting its pivotal role as the critical component in ML for combating EV71.</p>
</sec>
<sec id="s3-5">
<title>3.5 Strong affinity between critical components of ML and EV71 target genes</title>
<p>We employed the String database to import twenty-five common targets of Quercetin and EV71. Meticulous analysis successfully identified the top ten interacting genes: <italic>akt1, ccnd1, ptgs2, tnf, casp3, hmox1, mapk8, il1b, il6,</italic> and <italic>nos3</italic>. Our objective was to pinpoint key components in ML that hold potential therapeutic efficacy against EV71. Ten key ingredients were selected from the potential components of ML against EV71: beta-sitosterol, arachidonic acid, tetramethoxyluteolin, Moracin D, Quercetin, beta-carotene, stigmasterol, kaempferol, Moracin E, and iristectorigenin A. These active ingredients were organized into a small molecule library, and molecular docking was performed with the top ten target genes to obtain binding energy values. A heatmap was generated to display the binding energy results (<xref ref-type="fig" rid="F3">Figure 3A</xref>). The results demonstrated that the binding energies between the target genes and the active components in the small molecule library were all &#x2264; &#x2212;4.25&#xa0;kcal&#xa0;mol<sup>&#x2212;1</sup>, indicating a strong interaction between the main active ingredients of ML and the macromolecular protein against EV71, specifically involving key residues. Quercetin exhibits a remarkable affinity towards the target mentioned above genes, thus enabling us to conduct a preliminary assessment of its efficacy in combating EV71. The results with strong binding ability were visualized using MOE 2019.0102 software (<xref ref-type="fig" rid="F3">Figure 3B</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Molecular docking. <bold>(A)</bold> Docking and binding ability of target gene and small molecule library molecule. <bold>(B)</bold> Molecular docking model. Red is alkyl conjugation, and green is van der Waals interaction.</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g003.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 NF-&#x3ba;B signaling pathway is the primary mechanism of Quercetin anti-EV71</title>
<p>Quercetin assumes a pivotal role in the efficacy of ML against EV71. We conducted an in-depth analysis to identify 25 target genes associated with Quercetin&#x2019;s action against EV71, followed by performing an enrichment analysis utilizing the DAVID database. This analysis yielded 402 enriched Gene Ontology (GO) items, encompassing 268 biological processes (BP), 75 cellular components (CC), and 59 molecular functions (MF) (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Additionally, KEGG pathway analysis identified 66 enriched signaling pathways (<xref ref-type="fig" rid="F4">Figure 4B</xref>). We selected the top 15 items based on their <italic>p</italic> values to investigate these findings further and visualized them using R 4.2.1 software. The enriched terms encompass diverse functions, including negative regulation of transcription from RNA polymerase II promoter, positive regulation of GTPase activity, cytosol, extracellular exosome, protein binding, and identical protein binding. In parallel, KEGG analysis revealed relevant pathways such as the NF-&#x3ba;B signaling pathway, IL-17 signaling pathway, and TNF signaling pathway. These comprehensive findings strongly suggest that Quercetin, the primary active ingredient in ML, may exert its antiviral effect against EV71 through involvement in these signaling pathways, mainly via the NF-&#x3ba;B signaling pathway.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>GO and KEGG enrichment analysis. <bold>(A)</bold> Functional enrichment of GO molecules. <bold>(B)</bold> KEGG metabolic pathway enrichment analysis.</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g004.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>3.7 Quercetin improves survival of EV71-infected RD cells by inhibiting the NF-&#x3ba;B signaling pathway</title>
<p>The CCK-8 assay was conducted to assess the cytotoxicity of different concentrations of Quercetin on RD cells at 24&#xa0;h, 48&#xa0;h, and 72&#xa0;h. It was determined that the maximum non-toxic concentration (TC<sub>0</sub>) of Quercetin on RD cells was 12.5&#xa0;&#x3bc;M (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Additionally, we employed GraphPad Prism version 8.0 software to compute the drug&#x2019;s EC50 (78.69&#xa0;&#x3bc;M) and IC50 (291.2&#xa0;&#x3bc;M) at the 48-h mark. Subsequently, we determined the selection index (SI) to be 3.7. The cytopathic effects of the virus on RD cells were observed, and the TCID<sub>50</sub> of the EV71 virus was calculated using the Reed-Muench method as 10<sup>&#x2212;4.5</sup>/mL. For subsequent experiments, a concentration of Quercetin below TC<sub>0</sub> (12.5&#xa0;&#x3bc;M) and 100 TCID<sub>50</sub> (10<sup>&#x2212;2.5</sup>/mL) of EV71 virus were selected for a 48-h assay.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Quercetin improves survival of EV71-infected RD cells. <bold>(A)</bold> Detection of Quercetin on RD cytotoxicity. Quercetin was serially diluted in media containing 2% FBS at concentrations of 0, 0.78125, 1.5625, 3.125, 6.25, 12.5, 25, 50, 100, and 200&#xa0;&#x3bc;M, and no quercetin was considered as a normal RD cell control. Subsequently, the cytotoxicity of Quercetin on RD cells was determined by the CCK-8 assay. Measure the absorbance at 450&#xa0;nm using a microplate reader. The TC<sub>0</sub> value was calculated as the maximum non-toxic concentration of the drug. Data are presented as mean values from three independent experiments. <bold>(B)</bold> Inhibitory effect of Quercetin on EV71 replication. Quercetin was diluted in DMEM with 2% FBS to 0, 1.5625, 3.125, 6.25 and 12.5&#xa0;&#x3bc;M. No quercetin was considered in the EV71-infected control group, and the antiviral effect of Quercetin was tested. Data are represented as means from three independent experiments, SD, and analyzed by one-way ANOVA, compared with the NC group (&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001). <bold>(C)</bold>Inhibitory effect of quercetin on EV71 virus TCID50. RD cells were infected with EV71 and treated with Quercetin. The replication ability of EV71 was significantly weakened upon quercetin treatment. These findings highlight the potent inhibitory effect of Quercetin on EV71 virus replication.</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g005.tif"/>
</fig>
<p>The effectiveness of different concentrations of Quercetin against the EV71 virus was assessed using the CCK-8 method. The results revealed that 12.5&#xa0;M Quercetin exhibited the most significant anti-EV71 virus effect. Compared to the cell control group (100% survival rate), the survival rates were 53.86% at 25&#xa0;&#x3bc;M, 76.11% at 12.5&#xa0;&#x3bc;M, 63.20% at 6.25&#xa0;&#x3bc;M, 52.82% at 3.125&#xa0;&#x3bc;M, 47.02% at 1.5625&#xa0;&#x3bc;M, and 35.51% in the virus group (<xref ref-type="fig" rid="F5">Figure 5B</xref>). The TCID50 detection results demonstrated a notable decrease in the virus replication capability of EV71 treated with Quercetin compared to RD cells infected with regular EV71. This observation exhibited a correlation with the varying concentrations of Quercetin utilized (<xref ref-type="fig" rid="F5">Figure 5C</xref>).</p>
<p>VP1 of the EV71 virus was co-stained with p-NF-&#x3ba;Bp65, TNF, and IL-1&#x3b2;. Co-localization of VP1 with p-NF-&#x3ba;Bp65, TNF, and IL-1&#x3b2; proteins was observed. The levels of p-NF-&#x3ba;Bp65, TNF, and IL-1&#x3b2; were significantly higher compared to the control group. In the quercetin treatment group, p-NF-&#x3ba;Bp65, TNF, and IL-1&#x3b2; levels showed a dose-dependent reduction (<xref ref-type="fig" rid="F6">Figure 6</xref>). These findings suggest that the anti-EV71 virus mechanism of Quercetin may involve the inhibition of the NF-&#x3ba;B signaling pathway. The Western blot results corroborated the findings observed in the Immunofluorescence analysis (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Quercetin inhibited the co-localization staining of NF-&#x3ba;B signaling pathway-related proteins and VP-1 in EV71-infected RD cells. <bold>(A)</bold> VP-1 and p-NF-&#x3ba;B p65 protein levels in RD cells. <bold>(B)</bold> VP-1 and TNF&#x3b1; protein levels in RD cells. <bold>(C)</bold> VP-1 and IL-1&#x3b2; protein levels in RD cells. (immunofluorescence, 600&#xd7;, scale bar: 20&#xa0;&#x3bc;m). Comparison with normal control group, &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.01. Comparison with EV71-infected group &#x0023;&#x0023;<italic>p</italic> &#x003C; 0.01.</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g006.tif"/>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Quercetin inhibited activation of the NF-&#x3ba;B signaling pathway in EV71-infected RD cells. <bold>(A)</bold> Western blot analysis was performed to evaluate the effect of Quercetin on the expression of proteins related to the NF-&#x3ba;B signaling pathway in EV71-infected RD cells. It was observed that EV71 infection triggered activation of the NF-&#x3ba;B signaling pathway. However, subsequent treatment with Quercetin resulted in attenuated activation of NF-&#x3ba;B. <bold>(B)</bold> After actin normalization, we assessed the ratio of related proteins within the NF-&#x3ba;B signaling pathway. Our statistical analysis showed that compared with the EV71 group, the difference was statistically significant (&#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001).</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g007.tif"/>
</fig>
</sec>
<sec id="s3-8">
<title>3.8 Quercetin inhibits the MAPK signaling pathway</title>
<p>JNK, ERK, and p38 are proteins related to the MAPK signaling pathway. The Western blotting results showed that the EV71 virus could cause overactivation of the MAPK pathway in RD cells, with increased expression and phosphorylation levels of JNK, ERK, and p38. Quercetin demonstrated a downregulation in the expression and inhibition of JNK, ERK, and p38 phosphorylation caused by EV71. Quercetin inhibited the MAPK signaling pathway activated by EV71 (<xref ref-type="fig" rid="F8">Figure 8</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Quercetin inhibits the activation of the MAPK signaling pathway in EV71-infected RD cells. <bold>(A)</bold> Using Western blot analysis, we assessed the effect of Quercetin on the expression of proteins within the MAPK signaling pathway in EV71-infected RD cells. Our findings suggest that EV71 infection triggers the activation of the MAPK signaling pathway. Subsequent quercetin treatment produced results consistent with the inhibitory effects observed in the NF-&#x3ba;B signaling pathway. <bold>(B)</bold> After actin normalization, we assessed the proportion of associated proteins within the MAPK signaling pathway. Our statistical analysis showed that compared with the EV71 group, the difference was statistically significant (&#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001).</p>
</caption>
<graphic xlink:href="fphar-14-1260288-g008.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>HFMD is a highly contagious viral illness primarily caused by enteroviruses, notably coxsackievirus A16 (CV-A16) and enterovirus 71 (<xref ref-type="bibr" rid="B3">Aswathyraj et al., 2016</xref>; <xref ref-type="bibr" rid="B88">Xing et al., 2014</xref>). Among them, EV71 is associated with the most severe symptoms and highest mortality rate (<xref ref-type="bibr" rid="B92">Yang et al., 2009</xref>; <xref ref-type="bibr" rid="B105">Zhang et al., 2010</xref>; <xref ref-type="bibr" rid="B40">Li et al., 2017</xref>). Unfortunately, no specific drugs are currently available for the treatment of these viruses (<xref ref-type="bibr" rid="B52">Ng et al., 2015</xref>). Extensive research efforts have been dedicated to developing anti-EV71 drugs over the past 50&#xa0;years (<xref ref-type="bibr" rid="B83">Wang et al., 2023</xref>). Traditional Chinese medicine has revealed promising monomers, such as glycyrrhizic acid, baicalin, indigo root, Quercetin, kaempferol, and apigenin, which possess anti-EV71 effects (<xref ref-type="bibr" rid="B76">Tsai et al., 2011</xref>; <xref ref-type="bibr" rid="B93">Yang et al., 2012</xref>; <xref ref-type="bibr" rid="B79">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="B103">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="B41">Li et al., 2015</xref>; <xref ref-type="bibr" rid="B81">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="B94">Yao et al., 2018</xref>; <xref ref-type="bibr" rid="B17">Dai et al., 2019</xref>). Some of these components are already utilized in clinical practice. While Western medicines exhibit satisfactory inhibitory effects on EV71 replication, their mechanisms often target a single aspect and carry a risk of carcinogenesis (<xref ref-type="bibr" rid="B24">Friedman et al., 2009</xref>; <xref ref-type="bibr" rid="B5">Brambilla et al., 2010</xref>). In contrast, traditional Chinese medicine embraces a holistic approach, exerting antiviral effects through overall balance. Chinese medicine is distinguished by its multifaceted components and targets, affordability, low toxicity, and minimal cancer risk (<xref ref-type="bibr" rid="B14">Csik&#xf3;s et al., 2021</xref>; <xref ref-type="bibr" rid="B107">Zhu et al., 2022</xref>). Its antiviral properties are achieved through antioxidant, immune regulatory effects (<xref ref-type="bibr" rid="B13">Colunga Biancatelli et al., 2020</xref>), inhibition of viral-induced inflammatory responses (<xref ref-type="bibr" rid="B42">Lim et al., 2018</xref>; <xref ref-type="bibr" rid="B64">Saeedi-Boroujeni and Mahmoudian-Sani, 2021</xref>), and suppression of virus replication by inhibiting oxidative stress (<xref ref-type="bibr" rid="B8">Chen et al., 2022</xref>).</p>
<p>ML, a traditional Chinese medicine, has significant medicinal value and has shown efficacy in treating metabolic disorders such as diabetes, dyslipidemia, obesity, atherosclerosis, and hypertension (<xref ref-type="bibr" rid="B101">Zhang et al., 2022</xref>; <xref ref-type="bibr" rid="B11">Cheng et al., 2022</xref>). Furthermore, ML has been identified as a potential treatment option for viral diseases (<xref ref-type="bibr" rid="B58">Pronin et al., 2021</xref>). Our research was primarily dedicated to unraveling the antiviral attributes of mulberry leaves (ML), identifying multiple active constituents with potent antiviral effects. An extensive body of research has effectively showcased the antiviral prowess of compounds such as Quercetin, kaempferol, and beta-carotene (<xref ref-type="bibr" rid="B66">Sheehan et al., 2012</xref>; <xref ref-type="bibr" rid="B19">Ding et al., 2018</xref>; <xref ref-type="bibr" rid="B67">Shen et al., 2021</xref>; <xref ref-type="bibr" rid="B6">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="B69">Shokry et al., 2023</xref>). Furthermore, stigmasterol has demonstrated its multifaceted potential, encompassing antioxidant, antiviral, antifungal, antibacterial, and anticancer properties, achieved through immune regulation and anti-inflammatory mechanisms (<xref ref-type="bibr" rid="B57">Petrera et al., 2014</xref>). Iristectorigenin A possesses antioxidant and anti-inflammatory effects (<xref ref-type="bibr" rid="B1">Al-Qudah et al., 2015</xref>; <xref ref-type="bibr" rid="B43">Lim et al., 2017</xref>). Moracin D and Moracin E exhibit antioxidant effects and hold substantial medicinal value in antiviral and anticancer research (<xref ref-type="bibr" rid="B97">Yoon et al., 2021</xref>; <xref ref-type="bibr" rid="B51">Mohan Kumar et al., 2022</xref>). These active constituents of ML exert antiviral effects through diverse mechanisms, highlighting the potential of ML in countering the EV71 virus. Furthermore, the collective antiviral impacts of these active constituents might demonstrate synergistic properties.</p>
<p>By examining 29 common targets shared by ML and EV71, we predicted the potential function of these genes in ML anti-E71 virus through network pharmacology studies. A number of these genes are involved in oxidative stress, inflammation, vascular permeability, and immune function. For example, <italic>AKT1</italic> activation promotes cell proliferation and suppresses cell apoptosis, making it a significant participant in EV71&#x2019;s immune-inflammation mechanism (<xref ref-type="bibr" rid="B68">Shi et al., 2013</xref>). <italic>IL-6, IL-1B,</italic> and <italic>TNF-&#x03B1;</italic> exhibit immunomodulatory and pro-inflammatory effects (<xref ref-type="bibr" rid="B49">Luo et al., 2019</xref>; <xref ref-type="bibr" rid="B96">Yi et al., 2020</xref>). <italic>MAPK1</italic> is crucial in the inflammatory response (<xref ref-type="bibr" rid="B89">Xu et al., 2023</xref>). Inhibiting <italic>CASP3</italic> activity reduces EV71 virus protein expression and replication and can trigger pyroptosis as an alternative to apoptosis, thereby hindering EV71 infection (<xref ref-type="bibr" rid="B70">Song et al., 2018</xref>). <italic>HMOX1</italic> contributes to the host&#x2019;s resistance to the virus through the oxidative stress defense system (<xref ref-type="bibr" rid="B104">Zhang et al., 2022</xref>). In summary, these target genes of ML employ diverse mechanisms to inhibit EV71 virus infection and exert their influence at various stages of disease development.</p>
<p>To elucidate the mechanism of ML against the EV71 virus, we conducted GO enrichment analysis on the key targets of Quercetin, the primary anti-EV71 component of ML, and performed KEGG enrichment analysis to predict associated signaling pathways responsible for the antiviral effect. The KEGG database encompasses diverse biological domains, furnishing extensive data and insights spanning genomics, proteomics, metabolomics, and more. This encompassing repository facilitates the identification of promising targets associated with drugs and ailments, along with pertinent signaling pathways and biological functions (<xref ref-type="bibr" rid="B47">Lu, et al., 2020</xref>). Rigorous procedures have been implemented to ascertain the dependability of our KEGG enrichment analysis outcomes. In this process, data sources are carefully reviewed, statistical significance is evaluated, cross-validation is carried out thoroughly, and the biological relevance of the data is carefully interpreted. The findings suggest a potential relationship between Quercetin and the NF-&#x3ba;B signaling pathway. This pathway, comprising canonical and non-canonical pathways, plays a vital role in various biological processes, including the regulation of B and T-cell immunity (<xref ref-type="bibr" rid="B48">Lu et al., 2021</xref>). Many viruses activate or evade antiviral immune responses through this pathway (<xref ref-type="bibr" rid="B72">Struzik and Szulc-D&#x105;browska, 2019</xref>; <xref ref-type="bibr" rid="B32">Khatiwada et al., 2017</xref>). EV71 triggers NLRP3 inflammasome activation via the NF-&#x3ba;B pathway, and inhibiting this pathway aids the host&#x2019;s defense against EV71 infection in the central nervous system (<xref ref-type="bibr" rid="B26">Gong et al., 2022</xref>). Severe EV71 infection is associated with significantly elevated TNF levels (<xref ref-type="bibr" rid="B21">Duan et al., 2014</xref>; <xref ref-type="bibr" rid="B73">Sun et al., 2018</xref>). The TNF-&#x3b1;-mediated NF-&#x3ba;B pathway is essential for inflammatory responses, and the 2C protein of EV71 promotes NF-&#x3ba;B activation via TNF-&#x3b1;. The activation of NF-&#x3ba;B can be triggered by the TNF-&#x3b1;-related factor 2, the MEK kinase 1, the IKK&#x3b1;, or the IKK&#x3b2; (<xref ref-type="bibr" rid="B106">Zheng et al., 2011</xref>).</p>
<p>To validate the antiviral effect and mechanism of ML, we conducted <italic>in vitro</italic> experiments to verify the antiviral activity of Quercetin, the primary active compound derived from ML. Immunofluorescence analysis was performed to assess the expression of essential proteins in the NF-&#x3ba;B signaling pathway. The results demonstrated that Quercetin exhibited significant inhibition against the EV71 virus. Pretreatment of the virus with Quercetin weakened its toxicity and directly killed it, leading to its antiviral effect in cell experiments. Immunofluorescence analysis revealed reduced protein levels of p-NF-&#x3ba;B p65, TNF-&#x3b1;, and IL-1&#x3b2; in the quercetin-treated group compared to the EV71 group. The NF-&#x3ba;B signaling pathway is crucial in the inflammatory response (<xref ref-type="bibr" rid="B54">Oeckinghaus et al., 2011</xref>). TNF-&#x3b1; activates the non-canonical NF-&#x3ba;B pathway, leading to an inflammatory response (<xref ref-type="bibr" rid="B98">Yu et al., 2020</xref>). Downstream kinase IKK&#x3b1; is activated by TNF-&#x3b1;, promoting NF-&#x3ba;B phosphorylation (<xref ref-type="bibr" rid="B75">Sun, 2011</xref>). IL-1&#x3b2; induces NF-&#x3ba;B inhibitor phosphorylation, translating NF-&#x3ba;B to the nucleus and transcription of cytokine and chemokine genes (<xref ref-type="bibr" rid="B12">Cheng et al., 2019</xref>). The mammalian NF-&#x3ba;B family comprises five distinct proteins: p50, p52, p65 (also recognized as RelA), RelB, and c-Rel. These NF-&#x3ba;B family constituents engage in diverse combinations of homo- and heterodimeric associations with each other, culminating in the formation of biologically active protein complexes. Among these, the p65-p50 heterodimer is the prevailing form within cellular contexts (<xref ref-type="bibr" rid="B7">Chen, et al., 1998</xref>). Notably, the p65 protein garners substantial attention among the five NF-&#x3ba;B family members due to its extensive scrutiny. This heightened focus is partly attributable to its role as an activating component within the p65-p50 heterodimeric complex (<xref ref-type="bibr" rid="B36">Lecoq, et al., 2017</xref>). Upon infection with a pathogen, the activation of the predominant p65-p50 heterodimer of NF-&#x3ba;B occurs, leading to the translocation of p65 and p50 into the nucleus (<xref ref-type="bibr" rid="B50">Medina et al., 2002</xref>). Additionally, the phosphorylation of I&#x3ba;B&#x3b1;, mediated by I&#x3ba;B induced by TNF-&#x3b1;, results in its ubiquitination. This process ultimately leads to the nuclear translocation of NF-&#x3ba;B and the regulation of target gene transcription (<xref ref-type="bibr" rid="B55">Papa et al., 2009</xref>). The nuclear translocation of NF-&#x3ba;B p65 and NF-&#x3ba;B p50 has been observed in the mouse liver following infection with the Dengue virus (DENV) (<xref ref-type="bibr" rid="B71">Sreekanth et al., 2020</xref>). This study investigated p65 and phosphor-p65 in the cytoplasm and nucleus of whole-cell lysates. Separate studies on these fractions would provide more insight into Quercetin&#x2019;s role in regulating nuclear translocation of p65. The inhibitory effect of Quercetin on the NF-&#x3ba;B signaling pathway and its ability to decrease the synthesis of pro-inflammatory cytokines, specifically TNF-&#x3b1; and IL-1&#x3b2;, as observed in the study conducted by (<xref ref-type="bibr" rid="B2">Bezzi et al., 2001</xref>), aligns with the findings of the current investigation, suggesting that this mechanism may contribute significantly to Quercetin&#x2019;s antiviral activity against EV71.</p>
<p>Moreover, our investigation into the conduction of the MAPK signaling pathway unveiled that Quercetin&#x2019;s impact on this pathway parallels that of the NF-&#x3ba;B signaling pathway. Notably, the inhibitory effect of Quercetin on both pathways follows a dose-dependent pattern. The MAPK signaling pathway employs at least three activation routes to transmit extracellular signals to the nucleus. These include the classical MAPK pathway, MAPK/ERK, the JNK/MAPK signaling pathway, and the p38/MAPK signaling pathway. The MAPK/ERK signaling pathway is activated by signals from cell surface receptors like receptor tyrosine kinases (RTKs) or G protein-coupled receptors (GPCRs) (<xref ref-type="bibr" rid="B18">Delire and St&#xe4;rkel, 2015</xref>). The process of ERK activation entails phosphorylation by activated RAF, subsequently activating MEK, resulting in the direct phosphorylation of ERK (<xref ref-type="bibr" rid="B45">Liu et al., 2018</xref>). It has been documented that garlic extract inhibits reticuloendotheliosis virus (REV) replication by suppressing ERK expression (<xref ref-type="bibr" rid="B80">Wang et al., 2017</xref>). DNA viruses, including Herpes Simplex Virus 1 (HSV-1), exploit the MAPK/ERK pathway for intercellular dissemination (<xref ref-type="bibr" rid="B22">DuShane and Maginnis, 2019</xref>; <xref ref-type="bibr" rid="B84">Watanabe et al., 2021</xref>). JNK, also recognized as stress-activated protein kinase (SAPK), represents a subfamily within the canonical MAPK signal transduction cascade (<xref ref-type="bibr" rid="B99">Zeke, et al., 2016</xref>; <xref ref-type="bibr" rid="B59">Pua, et al., 2022</xref>). JNK proteins promptly respond to various cellular stimuli, including inflammatory cytokines, growth factors, ultraviolet radiation, bacterial and viral infections, heat shock, and osmotic and genotoxic stress (<xref ref-type="bibr" rid="B35">Kusumaningrum, et al., 2018</xref>). The promotion of Duck Plague Virus (DPV) proliferation has been documented through the inhibition of the immune interferon (IFN) signaling pathway and inflammatory pathways by JNK, as reported by <xref ref-type="bibr" rid="B86">Wu, et al. (2022)</xref>. Furthermore, the activation of JNK plays a crucial role in Varicella-Zoster Virus (VZV) protein expression and replication, as highlighted by <xref ref-type="bibr" rid="B34">Kurapati et al. (2017)</xref>. p38 mitogen-activated protein kinases form a class of evolutionarily conserved serine/threonine kinases. They function as intermediaries, connecting extracellular signals to intracellular processes that regulate a multitude of cellular functions (<xref ref-type="bibr" rid="B23">Falcicchia, et al., 2020</xref>; <xref ref-type="bibr" rid="B62">Romero-Becerra, et al., 2020</xref>). Various extracellular stimuli can phosphorylate p38 through the classical MAPK kinase (MAP3K)&#x2013;MAP kinase kinase (MKK) pathway. Phosphorylated p38, in turn, activates an array of transcription factors, protein kinases, cytoplasmic and nuclear proteins, and substrates downstream of this phosphorylation encompass the regulation of inflammatory responses, cell differentiation, apoptosis, and more (<xref ref-type="bibr" rid="B95">Yao, et al., 2020</xref>; <xref ref-type="bibr" rid="B25">Garc&#xed;a-Hern&#xe1;ndez, et al., 2021</xref>; <xref ref-type="bibr" rid="B53">O&#x27;Neil, et al., 2018</xref>). Indeed, recent studies have demonstrated that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the activation of p38/MAPK, resulting in an upregulation of proinflammatory cytokines and an enhanced replication of the virus (<xref ref-type="bibr" rid="B4">Bouhaddou et al., 2020</xref>). It has been observed that inhibiting the p38/MAPK signaling pathway can effectively mitigate the Influenza virus (IV) replication and the excessive production of proinflammatory mediators (<xref ref-type="bibr" rid="B91">Yang et al., 2022</xref>). Additionally, the infection of Newcastle Disease Virus (NDV) has been shown to induce the activation of p38/MAPK/Mnk1 signaling, facilitating the efficient synthesis of viral proteins (<xref ref-type="bibr" rid="B100">Zhan et al., 2020</xref>). Previous research has indicated that inhibiting the MAPK signaling pathway has significant implications in the context of viral infections (<xref ref-type="bibr" rid="B74">Sun et al., 2023</xref>). The infection caused by EV71 is closely linked to the signaling pathways of JNK and p38 MAPK, which in turn activate the MAPK pathway, increasing virus production and releasing proinflammatory cytokines (<xref ref-type="bibr" rid="B56">Peng et al., 2014</xref>). EV71 triggers the activation of the ERK MAPK pathway through the induction of c-Src-mediated epidermal growth factor receptor (EGFR) activation (<xref ref-type="bibr" rid="B85">Wong et al., 2005</xref>; <xref ref-type="bibr" rid="B77">Tung et al., 2011</xref>). Inflammation occurs as a result of the activation of the MAPK pathway downstream of the NF-&#x3ba;B signaling pathway (<xref ref-type="bibr" rid="B63">Roth Flach et al., 2015</xref>; <xref ref-type="bibr" rid="B61">Ramalingam et al., 2020</xref>). In contrast, an overabundance of phosphorylation in downstream proteins of MAPK has the potential to induce the release and nuclear translocation of NF-&#x3ba;B, thereby intensifying the inflammatory response (<xref ref-type="bibr" rid="B65">Schulze-Osthoff et al., 1997</xref>; <xref ref-type="bibr" rid="B55">Papa et al., 2009</xref>; <xref ref-type="bibr" rid="B71">Sreekanth et al., 2020</xref>; <xref ref-type="bibr" rid="B44">Liu et al., 2022</xref>). Our research findings underscore that Quercetin orchestrates the modulation of the inflammatory response through these three MAPK pathways. This influence encompasses the phosphorylation of p65 by inhibiting the MAPK signaling pathway. Quercetin further curtails the inflammatory response by inhibiting the NF-&#x3ba;B signaling pathway, thus presenting a multifaceted mechanism for mitigating inflammation.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>In conclusion, this study employed network pharmacology and <italic>in vitro</italic> experiments to investigate the mechanism of action of ML against EV71 virus infection. The findings reveal that ML exerts a substantial pharmacological effect against EV71 virus infection through a multi-component, multi-target, and multi-pathway approach. Quercetin, as the primary active component of ML, plays a pivotal role in inhibiting EV71 virus infection by targeting the NF-&#x3ba;B signaling pathway. These results provide valuable insights into the therapeutic mechanism of ML in the treatment of EV71 virus infection.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>TL: Writing&#x2013;original draft, Data curation, Formal Analysis, Software. YL: Data curation, Writing&#x2013;original draft. LW: Data curation, Writing&#x2013;original draft. XZ: Writing&#x2013;original draft, Investigation. YZ: Investigation, Writing&#x2013;original draft. XG: Writing&#x2013;original draft, Formal Analysis. LC: Formal Analysis, Writing&#x2013;original draft. LL: Writing&#x2013;original draft, Conceptualization, Methodology, Project administration. LY: Methodology, Project administration, Writing&#x2013;original draft. BW: Conceptualization, Project administration, Writing&#x2013;original draft.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>The authors declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Heilongjiang Provincial Natural Science Foundation of China (LH2021H111), the features subject of research and development of oral biomedical materials and personalized manufacturing, North Medicine and Functional Food Characteristic Subject Project in Heilongjiang Province (No. HLJTSXK-2022-03), Key Laboratory of Microecology-immune Regulatory Network and Related Diseases open project (2022-SZD-JC003).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Qudah</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Saleh</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Al-Jaber</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Tashtoush</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Lahham</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Abu Zarga</surname>
<given-names>M. H.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>New isoflavones from Gynandriris sisyrinchium and their antioxidant and cytotoxic activities</article-title>. <source>Fitoterapia</source> <volume>107</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2015.09.020</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aswathyraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Arunkumar</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alidjinou</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Hober</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Hand, foot and mouth disease (HFMD): Emerging epidemiology and the need for a vaccine strategy</article-title>. <source>Med. Microbiol. Immunol.</source> <volume>205</volume> (<issue>5</issue>), <fpage>397</fpage>&#x2013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1007/s00430-016-0465-y</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bezzi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Domercq</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schols</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Clercq</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>XCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity</article-title>. <source>Nat. Neurosci.</source> <volume>4</volume> (<issue>7</issue>), <fpage>702</fpage>&#x2013;<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1038/89490</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouhaddou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Memon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Rezelj</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Correa Marrero</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The global phosphorylation landscape of SARS-CoV-2 infection</article-title>. <source>Cell.</source> <volume>182</volume> (<issue>3</issue>), <fpage>685</fpage>&#x2013;<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.06.034</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brambilla</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mattioli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Genotoxic and carcinogenic effects of gastrointestinal drugs</article-title>. <source>Mutagenesis</source> <volume>25</volume> (<issue>4</issue>), <fpage>315</fpage>&#x2013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1093/mutage/geq025</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z. C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H. F.</given-names>
</name>
</person-group> (<year>2022a</year>). <article-title>First discovery of beta-sitosterol as a novel antiviral agent against white spot syndrome virus</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>18</issue>), <fpage>10448</fpage>. <pub-id pub-id-type="doi">10.3390/ijms231810448</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F. E.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. Q.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA</article-title>. <source>Nature</source> <volume>391</volume> (<issue>6665</issue>), <fpage>410</fpage>&#x2013;<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1038/34956</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Quercetin inhibits Hsp70 blocking of bovine viral diarrhea virus infection and replication in the early stage of virus infection</article-title>. <source>Viruses</source> <volume>14</volume> (<issue>11</issue>), <fpage>2365</fpage>. <pub-id pub-id-type="doi">10.3390/v14112365</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mulberry leaf polysaccharide supplementation contributes to enhancing the respiratory mucosal barrier immune response in Newcastle disease virus-vaccinated chicks</article-title>. <source>Poult. Sci.</source> <volume>100</volume> (<issue>4</issue>), <fpage>101043</fpage>. <pub-id pub-id-type="doi">10.1016/j.psj.2021.101043</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>S. Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Research progress on antiviral constituents in traditional Chinese medicines and their mechanisms of action</article-title>. <source>Pharm. Biol.</source> <volume>60</volume> (<issue>1</issue>), <fpage>1063</fpage>&#x2013;<lpage>1076</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2022.2074053</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Mulberry leaf activates brown adipose tissue and induces browning of inguinal white adipose tissue in type 2 diabetic rats through regulating AMP-activated protein kinase signalling pathway</article-title>. <source>Br. J. Nutr.</source> <volume>127</volume> (<issue>6</issue>), <fpage>810</fpage>&#x2013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114521001537</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>S Pang</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C. Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Quercetin inhibits the production of IL-1&#x3b2;-induced inflammatory cytokines and chemokines in ARPE-19 cells via the MAPK and NF-&#x3ba;B signaling pathways</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>12</issue>), <fpage>2957</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20122957</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colunga Biancatelli</surname>
<given-names>R. M. L.</given-names>
</name>
<name>
<surname>Berrill</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Catravas</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Marik</surname>
<given-names>P. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Quercetin and vitamin C: An experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)</article-title>. <source>Front. Immunol.</source> <volume>11</volume>, <fpage>1451</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2020.01451</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csik&#xf3;s</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Horv&#xe1;th</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>&#xc1;cs</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bal&#xe1;zs</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Dolenc</surname>
<given-names>M. S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Treatment of benign prostatic hyperplasia by natural drugs</article-title>. <source>Mol. (Basel, Switz.</source> <volume>26</volume> (<issue>23</issue>), <fpage>7141</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26237141</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Berberine prevents lethal EV71 neurological infection in newborn mice</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>1027566</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.1027566</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Network pharmacology analysis on the mechanism of huangqi sijunzi decoction in treating cancer-related fatigue</article-title>. <source>J. Healthc. Eng.</source> <volume>2021</volume>, <fpage>9780677</fpage>. <pub-id pub-id-type="doi">10.1155/2021/9780677</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Antiviral efficacy of flavonoids against enterovirus 71 infection <italic>in vitro</italic> and in newborn mice</article-title>. <source>Viruses</source> <volume>11</volume> (<issue>7</issue>), <fpage>625</fpage>. <pub-id pub-id-type="doi">10.3390/v11070625</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delire</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>St&#xe4;rkel</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The ras/MAPK pathway and hepatocarcinoma: Pathogenesis and therapeutic implications</article-title>. <source>Eur. J. Clin. Invest.</source> <volume>45</volume> (<issue>6</issue>), <fpage>609</fpage>&#x2013;<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1111/eci.12441</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome</article-title>. <source>Phytomedicine Int. J. phytotherapy Phytopharm.</source> <volume>41</volume>, <fpage>45</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2018.01.026</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Serum inflammatory cytokine levels correlate with hand-foot-mouth disease severity: A nested serial case-control study</article-title>. <source>PloS one</source> <volume>9</volume> (<issue>11</issue>), <fpage>e112676</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112676</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DuShane</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Maginnis</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Human DNA virus exploitation of the MAPK-ERK cascade</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>14</issue>), <fpage>3427</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20143427</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falcicchia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tozzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Arancio</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Watterson</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Origlia</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Involvement of p38 MAPK in synaptic function and dysfunction</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>16</issue>), <fpage>5624</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21165624</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Udaltsova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Quesenberry</surname>
<given-names>C. P.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Habel</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Screening pharmaceuticals for possible carcinogenic effects: Initial positive results for drugs not previously screened</article-title>. <source>Cancer causes control CCC</source> <volume>20</volume> (<issue>10</issue>), <fpage>1821</fpage>&#x2013;<lpage>1835</lpage>. <pub-id pub-id-type="doi">10.1007/s10552-009-9375-2</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garc&#xed;a-Hern&#xe1;ndez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Ortega</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Ruiz-Alcal&#xe1;</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Carrillo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Marchal</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Garc&#xed;a</surname>
<given-names>M. &#xc1;.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The p38 MAPK components and modulators as biomarkers and molecular targets in cancer</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>1</issue>), <fpage>370</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23010370</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Phosphorylation of ERK-dependent NF-&#x3ba;B triggers NLRP3 inflammasome mediated by vimentin in EV71-infected glioblastoma cells</article-title>. <source>Mol. (Basel, Switz.</source> <volume>27</volume> (<issue>13</issue>), <fpage>4190</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27134190</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hanaoka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Enterovirus-associated hand-foot and mouth disease and neurological complications in Japan and the rest of the world</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>20</issue>), <fpage>5201</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20205201</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>COVID-19: Antiviral agents, antibody development and traditional Chinese medicine</article-title>. <source>Virol. Sin.</source> <volume>35</volume> (<issue>6</issue>), <fpage>685</fpage>&#x2013;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1007/s12250-020-00297-0</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Antiviral effects of the petroleum ether extract of Tournefortia sibirica L. against enterovirus 71 infection <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>999798</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.999798</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71</article-title>. <source>J. Ethnopharmacol.</source> <volume>266</volume>, <fpage>113401</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2020.113401</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khatiwada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Delhon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nagendraprabhu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chaulagain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Diel</surname>
<given-names>D. G.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>A parapoxviral virion protein inhibits NF-&#x3ba;B signaling early in infection</article-title>. <source>PLoS Pathog.</source> <volume>13</volume> (<issue>8</issue>), <fpage>e1006561</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006561</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurapati</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sadaoka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rajbhandari</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jagdish</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Role of the JNK pathway in varicella-zoster virus lytic infection and reactivation</article-title>. <source>J. virology</source> <volume>91</volume> (<issue>17</issue>), <fpage>006400</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00640-17</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kusumaningrum</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Gasdermin C is induced by ultraviolet light and contributes to MMP-1 expression via activation of ERK and JNK pathways</article-title>. <source>J. dermatological Sci.</source> <volume>90</volume> (<issue>2</issue>), <fpage>180</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdermsci.2018.01.015</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecoq</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Raiola</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chabot</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Cyr</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Arseneault</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Legault</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-&#x3ba;B and transcription regulatory factors</article-title>. <source>Nucleic acids Res.</source> <volume>45</volume> (<issue>9</issue>), <fpage>5564</fpage>&#x2013;<lpage>5576</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx146</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J. T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Honeysuckle aqueous extracts induced let-7a suppress EV71 replication and pathogenesis <italic>in vitro</italic> and <italic>in vivo</italic> and is predicted to inhibit SARS-CoV-2</article-title>. <source>Viruses</source> <volume>13</volume> (<issue>2</issue>), <fpage>308</fpage>. <pub-id pub-id-type="doi">10.3390/v13020308</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H. Q.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>H. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects</article-title>. <source>Biomed. Pharmacother. &#x3d; Biomedecine Pharmacother.</source> <volume>130</volume>, <fpage>110641</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2019.110641</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Discovery of potent EV71 capsid inhibitors for treatment of HFMD</article-title>. <source>ACS Med. Chem. Lett.</source> <volume>8</volume> (<issue>8</issue>), <fpage>841</fpage>&#x2013;<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1021/acsmedchemlett.7b00188</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The antiviral effect of baicalin on enterovirus 71 <italic>in vitro</italic>
</article-title>. <source>Viruses</source> <volume>7</volume> (<issue>8</issue>), <fpage>4756</fpage>&#x2013;<lpage>4771</lpage>. <pub-id pub-id-type="doi">10.3390/v7082841</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Flavonoids interfere with NLRP3 inflammasome activation</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>355</volume>, <fpage>93</fpage>&#x2013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2018.06.022</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Methyl caffeate and some plant constituents inhibit age-related inflammation: Effects on senescence-associated secretory phenotype (SASP) formation</article-title>. <source>Archives pharmacal Res.</source> <volume>40</volume> (<issue>4</issue>), <fpage>524</fpage>&#x2013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1007/s12272-017-0909-y</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Dental pulp stem cell-derived exosomes suppress M1 macrophage polarization through the ROS-MAPK-NF&#x3ba;B p65 signaling pathway after spinal cord injury</article-title>. <source>J. nanobiotechnology</source> <volume>20</volume> (<issue>1</issue>), <fpage>65</fpage>. <pub-id pub-id-type="doi">10.1186/s12951-022-01273-4</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Targeting ERK, an Achilles&#x27; Heel of the MAPK pathway, in cancer therapy</article-title>. <source>Acta Pharm. Sin. B</source> <volume>8</volume> (<issue>4</issue>), <fpage>552</fpage>&#x2013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2018.01.008</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z. F.</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>Q. H.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>C. Z.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Molecular epidemiology and evolution of human enterovirus 71 and hand, foot and mouth disease</article-title>. <source>Yi chuan &#x3d; Hered.</source> <volume>37</volume> (<issue>5</issue>), <fpage>426</fpage>&#x2013;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.16288/j.yczz.14-255</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>RNA-seq revealed a circular RNA-microRNA-mRNA regulatory network in hantaan virus infection</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>10</volume>, <fpage>97</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2020.00097</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Interplay between non-canonical NF-&#x3ba;B signaling and hepatitis B virus infection</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>730684</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.730684</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shereen</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production</article-title>. <source>PLoS Pathog.</source> <volume>15</volume> (<issue>11</issue>), <fpage>e1008142</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1008142</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chhatwal</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Induction of NF-kappaB nuclear translocation in human respiratory epithelial cells by group A streptococci</article-title>. <source>Microb. Pathog.</source> <volume>33</volume> (<issue>6</issue>), <fpage>307</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1006/mpat.2002.0532</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohan Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Anantapur</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>H V</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Computational investigation of phytoalexins as potential antiviral RAP-1 and RAP-2 (replication associated proteins) inhibitor for the management of cucumber mosaic virus (CMV): A molecular modeling, <italic>in silico</italic> docking and MM-GBSA study</article-title>. <source>J. Biomol. Struct. Dyn.</source> <volume>40</volume> (<issue>22</issue>), <fpage>12165</fpage>&#x2013;<lpage>12183</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2021.1968500</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kwang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Recent progress towards novel EV71 anti-therapeutics and vaccines</article-title>. <source>Viruses</source> <volume>7</volume> (<issue>12</issue>), <fpage>6441</fpage>&#x2013;<lpage>6457</lpage>. <pub-id pub-id-type="doi">10.3390/v7122949</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Neil</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Ammit</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>MAPK p38 regulates inflammatory gene expression via tristetraprolin: Doing good by stealth</article-title>. <source>Int. J. Biochem. Cell. Biol.</source> <volume>94</volume>, <fpage>6</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2017.11.003</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oeckinghaus</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hayden</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Crosstalk in NF-&#x3ba;B signaling pathways</article-title>. <source>Nat. Immunol.</source> <volume>12</volume> (<issue>8</issue>), <fpage>695</fpage>&#x2013;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2065</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bubici</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zazzeroni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Franzoso</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Mechanisms of liver disease: Cross-talk between the NF-kappaB and JNK pathways</article-title>. <source>Biol. Chem.</source> <volume>390</volume> (<issue>10</issue>), <fpage>965</fpage>&#x2013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1515/BC.2009.111</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells</article-title>. <source>BMC Microbiol.</source> <volume>14</volume>, <fpage>147</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2180-14-147</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrera</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>N&#xed;ttolo</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Alch&#xe9;</surname>
<given-names>L. E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Antiviral action of synthetic stigmasterol derivatives on herpes simplex virus replication in nervous cells <italic>in vitro</italic>
</article-title>. <source>BioMed Res. Int.</source> <volume>2014</volume>, <fpage>947560</fpage>. <pub-id pub-id-type="doi">10.1155/2014/947560</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pronin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Narovlyansky</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Sanin</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>New approaches to the prevention and treatment of viral diseases</article-title>. <source>Archivum Immunol. Ther. Exp.</source> <volume>69</volume> (<issue>1</issue>), <fpage>10</fpage>. <pub-id pub-id-type="doi">10.1007/s00005-021-00613-w</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pua</surname>
<given-names>L. J. W.</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Khoo</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>C. O.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>W. M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Functional roles of JNK and p38 MAPK signaling in nasopharyngeal carcinoma</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>3</issue>), <fpage>1108</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23031108</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma</article-title>. <source>Biosci. trends</source> <volume>15</volume> (<issue>4</issue>), <fpage>201</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.5582/bst.2021.01263</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramalingam</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Poulos</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Lazzari</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gutkin</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kloss</surname>
<given-names>C. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Chronic activation of endothelial MAPK disrupts hematopoiesis via NFKB dependent inflammatory stress reversible by SCGF</article-title>. <source>Nat. Commun.</source> <volume>11</volume> (<issue>1</issue>), <fpage>666</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-14478-8</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero-Becerra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Santamans</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Folgueira</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sabio</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>p38 MAPK pathway in the heart: New insights in health and disease</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>19</issue>), <fpage>7412</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21197412</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth Flach</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Skoura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matevossian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Danai</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cortes</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis</article-title>. <source>Nat. Commun.</source> <volume>6</volume>, <fpage>8995</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms9995</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saeedi-Boroujeni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahmoudian-Sani</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Anti-inflammatory potential of Quercetin in COVID-19 treatment</article-title>. <source>J. Inflamm. Lond. Engl.</source> <volume>18</volume> (<issue>1</issue>), <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/s12950-021-00268-6</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulze-Osthoff</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Riehemann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wesselborg</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Regulation of NF-kappa B activation by MAP kinase cascades</article-title>. <source>Immunobiology</source> <volume>198</volume> (<issue>1-3</issue>), <fpage>35</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/s0171-2985(97)80025-3</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheehan</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>van Heeswijk</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Singhal</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Seguin</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>The effect of &#x3b2;-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients</article-title>. <source>Mol. (Basel, Switz.</source> <volume>17</volume> (<issue>1</issue>), <fpage>688</fpage>&#x2013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.3390/molecules17010688</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ba</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Quercetin-mediated SIRT1 activation attenuates collagen-induced mice arthritis</article-title>. <source>J. Ethnopharmacol.</source> <volume>279</volume>, <fpage>114213</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2021.114213</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Differential gene expressions of the MAPK signaling pathway in enterovirus 71-infected rhabdomyosarcoma cells</article-title>. <source>Braz. J. Infect. Dis. official Publ. Braz. Soc. Infect. Dis.</source> <volume>17</volume> (<issue>4</issue>), <fpage>410</fpage>&#x2013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjid.2012.11.009</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shokry</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hegazy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abbas</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Mostafa</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Eissa</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Metwaly</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Phytoestrogen &#x3b2;-sitosterol exhibits potent <italic>in vitro</italic> antiviral activity against influenza A viruses</article-title>. <source>Vaccines</source> <volume>11</volume> (<issue>2</issue>), <fpage>228</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines11020228</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solomon</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lewthwaite</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cardosa</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>McMinn</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Virology, epidemiology, pathogenesis, and control of enterovirus 71</article-title>. <source>Lancet Infect. Dis.</source> <volume>10</volume> (<issue>11</issue>), <fpage>778</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(10)70194-8</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Caspase-3 inhibition attenuates the cytopathic effects of EV71 infection</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>, <fpage>817</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.00817</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sreekanth</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Chuncharunee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yenchitsomanus</surname>
<given-names>P. T.</given-names>
</name>
<name>
<surname>Limjindaporn</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Crocetin improves Dengue virus-induced liver injury</article-title>. <source>Viruses</source> <volume>12</volume> (<issue>8</issue>), <fpage>825</fpage>. <pub-id pub-id-type="doi">10.3390/v12080825</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Struzik</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Szulc-D&#x105;browska</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Manipulation of non-canonical NF-&#x3ba;B signaling by non-oncogenic viruses</article-title>. <source>Archivum Immunol. Ther. Exp.</source> <volume>67</volume> (<issue>1</issue>), <fpage>41</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1007/s00005-018-0522-x</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B. X.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Correlation analysis on serum inflammatory cytokine level and neurogenic pulmonary edema for children with severe hand-foot-mouth disease</article-title>. <source>Eur. J. Med. Res.</source> <volume>23</volume> (<issue>1</issue>), <fpage>21</fpage>. <pub-id pub-id-type="doi">10.1186/s40001-018-0313-1</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Inhibitory effects and mechanisms of proanthocyanidins against enterovirus 71 infection</article-title>. <source>Virus Res.</source> <volume>329</volume>, <fpage>199098</fpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2023.199098</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Non-canonical NF-&#x3ba;B signaling pathway</article-title>. <source>Cell. Res.</source> <volume>21</volume> (<issue>1</issue>), <fpage>71</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2010.177</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>C. H.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins</article-title>. <source>Food Chem.</source> <volume>128</volume> (<issue>2</issue>), <fpage>312</fpage>&#x2013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2011.03.022</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tung</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I. T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: Role of the c-src/EGFR/p42/p44 MAPK/CREB signaling pathway</article-title>. <source>J. Cell. Biochem.</source> <volume>112</volume> (<issue>2</issue>), <fpage>559</fpage>&#x2013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.22946</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease</article-title>. <source>J. Ethnopharmacol.</source> <volume>147</volume> (<issue>1</issue>), <fpage>114</fpage>&#x2013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2013.02.017</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Allicin alleviates reticuloendotheliosis virus-induced immunosuppression via ERK/Mitogen-Activated protein kinase pathway in specific pathogen-free chickens</article-title>. <source>Front. Immunol.</source> <volume>8</volume>, <fpage>1856</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01856</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Chinese herbal medicines as a source of molecules with anti-enterovirus 71 activity</article-title>. <source>Chin. Med.</source> <volume>11</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/s13020-016-0074-0</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Neutrophil extracellular traps induced by VP1 contribute to pulmonary edema during EV71 infection</article-title>. <source>Cell. death Discov.</source> <volume>5</volume>, <fpage>111</fpage>. <pub-id pub-id-type="doi">10.1038/s41420-019-0193-3</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Advances in anti-EV-A71 drug development research</article-title>. <source>J. Adv. Res.</source> <volume>S2090-1232</volume> (<issue>23</issue>), <fpage>00089</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jare.2023.03.007</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arii</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Takeshima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fukui</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shimojima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kozuka-Hata</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Prohibitin-1 contributes to cell-to-cell transmission of herpes simplex virus 1 via the MAPK/ERK signaling pathway</article-title>. <source>J. virology</source> <volume>95</volume> (<issue>3</issue>), <fpage>e01413</fpage>&#x2013;<lpage>e01420</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01413-20</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Horng</surname>
<given-names>J. T.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71</article-title>. <source>Life Sci.</source> <volume>78</volume> (<issue>1</issue>), <fpage>82</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2005.04.076</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Duck plague virus negatively regulates IFN signaling to promote virus proliferation via JNK signaling pathway</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <fpage>935454</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.935454</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W. N.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. P.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T. F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>How Chinese herbal medicine prevents epidemics: From ancient pestilences to COVID-19 pandemic</article-title>. <source>Am. J. Chin. Med.</source> <volume>49</volume> (<issue>5</issue>), <fpage>1017</fpage>&#x2013;<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1142/S0192415X2150049X</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xing</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Viboud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J. T.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Hand, foot, and mouth disease in China, 2008-12: An epidemiological study</article-title>. <source>Infect. Dis.</source> <volume>14</volume> (<issue>4</issue>), <fpage>308</fpage>&#x2013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(13)70342-6</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Herpes simplex virus 1-induced ferroptosis contributes to viral encephalitis</article-title>. <source>mBio</source> <volume>14</volume> (<issue>1</issue>), <fpage>e0237022</fpage>. <pub-id pub-id-type="doi">10.1128/mbio.02370-22</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>Role of non-coding RNA in neurological complications associated with enterovirus 71</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>12</volume>, <fpage>873304</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2022.873304</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>5-Methoxyflavone-induced AMPK&#x3b1; activation inhibits NF-&#x3ba;B and p38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>Cell. Mol. Biol. Lett.</source> <volume>27</volume> (<issue>1</issue>), <fpage>82</fpage>. <pub-id pub-id-type="doi">10.1186/s11658-022-00381-1</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>McNutt</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the people&#x27;s Republic of China: A histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study</article-title>. <source>Hum. Pathol.</source> <volume>40</volume> (<issue>9</issue>), <fpage>1288</fpage>&#x2013;<lpage>1295</lpage>. <pub-id pub-id-type="doi">10.1016/j.humpath.2009.01.015</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>
<italic>In vitro</italic> inhibition of influenza virus infection by a crude extract from Isatis indigotica root resulting in the prevention of viral attachment</article-title>. <source>Mol. Med. Rep.</source> <volume>5</volume> (<issue>3</issue>), <fpage>793</fpage>&#x2013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2011.709</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Inhibition of enterovirus 71 replication and viral 3C protease by Quercetin</article-title>. <source>Virology J.</source> <volume>15</volume> (<issue>1</issue>), <fpage>116</fpage>. <pub-id pub-id-type="doi">10.1186/s12985-018-1023-6</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Dioscin facilitates ROS-induced apoptosis via the p38-MAPK/HSP27-mediated pathways in lung squamous cell carcinoma</article-title>. <source>Int. J. Biol. Sci.</source> <volume>16</volume> (<issue>15</issue>), <fpage>2883</fpage>&#x2013;<lpage>2894</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.45710</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Hepatitis B core antigen impairs the polarization while promoting the production of inflammatory cytokines of M2 macrophages via the TLR2 pathway</article-title>. <source>Front. Immunol.</source> <volume>11</volume>, <fpage>535</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2020.00535</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>W. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Moracin D induces apoptosis in prostate cancer cells via activation of PPAR gamma/PKC delta and inhibition of PKC alpha</article-title>. <source>Phytotherapy Res. PTR</source> <volume>35</volume> (<issue>12</issue>), <fpage>6944</fpage>&#x2013;<lpage>6953</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.7313</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Targeting NF-&#x3ba;B pathway for the therapy of diseases: Mechanism and clinical study</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>5</volume> (<issue>1</issue>), <fpage>209</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-020-00312-6</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Misheva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rem&#xe9;nyi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bogoyevitch</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>JNK signaling: Regulation and functions based on complex protein-protein partnerships</article-title>. <source>Microbiol. Mol. Biol. Rev. MMBR</source> <volume>80</volume> (<issue>3</issue>), <fpage>793</fpage>&#x2013;<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00043-14</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Newcastle Disease virus infection activates PI3K/Akt/mTOR and p38 MAPK/Mnk1 pathways to benefit viral mRNA translation via interaction of the viral NP protein and host eIF4E</article-title>. <source>PLoS Pathog.</source> <volume>16</volume> (<issue>6</issue>), <fpage>e1008610</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1008610</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022a</year>). <article-title>Mulberry leaf (morus alba L.): A review of its potential influences in mechanisms of action on metabolic diseases</article-title>. <source>Pharmacol. Res.</source> <volume>175</volume>, <fpage>106029</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2021.106029</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aliyari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022b</year>). <article-title>SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1</article-title>. <source>Cell. Mol. Immunol.</source> <volume>19</volume> (<issue>8</issue>), <fpage>872</fpage>&#x2013;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1038/s41423-022-00887-w</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors</article-title>. <source>PloS one</source> <volume>9</volume> (<issue>10</issue>), <fpage>e110429</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0110429</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2022c</year>). <article-title>Hand-Foot-and-Mouth disease-associated enterovirus and the development of multivalent HFMD vaccines</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume> (<issue>1</issue>), <fpage>169</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24010169</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China</article-title>. <source>Virology J.</source> <volume>7</volume>, <fpage>94</fpage>. <pub-id pub-id-type="doi">10.1186/1743-422X-7-94</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Enterovirus 71 2C protein inhibits TNF-&#x3b1;-mediated activation of NF-&#x3ba;B by suppressing I&#x3ba;B kinase &#x3b2; phosphorylation</article-title>. <source>J. Immunol. Baltim. Md, 1950)</source> <volume>187</volume> (<issue>5</issue>), <fpage>2202</fpage>&#x2013;<lpage>2212</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1100285</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbs</article-title>. <source>Biomed. Pharmacother. &#x3d; Biomedecine Pharmacother.</source> <volume>148</volume>, <fpage>112719</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.112719</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>